J. R. Srigley, B. Delahunt, and J. N. Eble, The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia. The American journal of surgical pathology, vol.37, pp.1469-1489, 2013.

R. J. Motzer, B. Escudier, and D. F. Mcdermott, Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma, N Engl J Med, vol.373, pp.1803-1813, 2015.

T. Powles, L. Albiges, and M. Staehler, Updated European Association of Urology Guidelines Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer, Eur Urol, 2017.

D. Y. Heng, W. Xie, and M. M. Regan, External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study, Lancet Oncol, vol.14, pp.141-148, 2013.

D. Y. Heng, M. J. Mackenzie, and U. N. Vaishampayan, Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy, Medical Oncology / ESMO, vol.23, pp.1549-1555, 2011.

A. M. Molina, X. Jia, and D. R. Feldman, Long-term response to sunitinib therapy for